Conversely, prior studies have reported that elevated RASD1 expression correlates with poor survival and chemotherapy resistance in B-cell acute lymphoblastic leukemia (B-ALL) [53]. This evidence concerns the gene RASD1 and precursor B-cell acute lymphoblastic leukemia.